Duopharma Biotech Bhd (XKLS:7148) Debt-to-Asset

: 0.43 (As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

Duopharma Biotech Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was RM227.2 Mil. Duopharma Biotech Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was RM362.7 Mil. Duopharma Biotech Bhd's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was RM1,383.5 Mil. Duopharma Biotech Bhd's debt to asset for the quarter that ended in Sep. 2023 was 0.43.

Duopharma Biotech Bhd Debt-to-Asset Historical Data

The historical data trend for Duopharma Biotech Bhd's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

0.29

0.35

Duopharma Biotech Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Asset	Get a 7-Day Free Trial															0.35	0.35	0.35	0.35	0.43

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Duopharma Biotech Bhd Debt-to-Asset Distribution

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Debt-to-Asset falls into.

Duopharma Biotech Bhd Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Duopharma Biotech Bhd's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(135.081	+	296.522)	/	1221.919
	=	0.35

Duopharma Biotech Bhd's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(227.154	+	362.677)	/	1383.502
	=	0.43

Duopharma Biotech Bhd (XKLS:7148) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Duopharma Biotech Bhd Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd (XKLS:7148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines